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doi:10.1016/j.jtcvs.2006.03.060bjectives: Resuming 2-lung ventilation from 1-lung ventilation might induce a re-
xpansion and reoxygenation effect. The oxidative stress during 1-lung ventilation/
-lung ventilation has not been studied, although severe complications, such as
e-expansion pulmonary edema, were reported. Reactive oxygen species production
nd total antioxidant status assay levels were measured in this study during 1-lung
entilation/2-lung ventilation. The effects on extravascular lung water, cardiac
utput, and intrathoracic blood volume were also studied by using the Pulsion
iCCO system.
ethods: Twenty patients undergoing 1-lung ventilation/2-lung ventilation (60
inutes) for video-assisted thoracoscopic surgery with minimal lung injuries were
ncluded in this study. Reactive oxygen species production was measured by means
f lucigenin (detecting superoxide mainly) and luminol (detecting H2O2 and HOCl
ainly) chemiluminescence. Reactive oxygen species production, total antioxidant
tatus assay (by using the Randox TAS kit), extravascular lung water, cardiac
utput, and intrathoracic blood volume values were measured before 1-lung venti-
ation (T1), before resuming 2-lung ventilation (T2), 5 minutes after 2-lung venti-
ation (T3), and 30 minutes after 2-lung ventilation (T4).
esults: One-lung ventilation time was 118  33 minutes. Lucigenin chemilumi-
escence (but not luminol chemiluminescence) increased significantly at T3 and T4.
otal antioxidant status decreased nonsignificantly. Extravascular lung water, in-
rathoracic blood volume, and permeability index values changed nonsignificantly
fter 2-lung ventilation. Cardiac output increased significantly at T4, and there is a
egative correlation between cardiac output and extravascular lung water (r 
0.431, P  .005).
onclusions: Resuming 2-lung ventilation induces a massive superoxide produc-
ion. Comparable extravascular lung water and intrathoracic blood volume and a
onsignificant decrease of total antioxidant status indicate adequate antioxidant
apacity to counteract it. Severe oxidative injuries after 1-lung ventilation/2-lung
entilation should be considered in patients without adequate antioxidative capacity,
uch as those with cancer and trauma.
ne-lung ventilation (OLV) for thoracotomy or thoracoscopy is frequently
applied for a clear operational field in thoracic surgery. During OLV, the
nonventilated lung not only remains atelectatic but also hypoperfused
ecause of hypoxic vasoconstriction. When resuming 2-lung ventilation (2LV),
e-expansion, along with oxygen re-entry through the airways, causes reactive
ulmonary vascular dilatation, commencing reperfusion of the lung, and thus
xcessive oxidative radicals might be released. Few experiments about oxidative
tress caused by OLV-2LV manipulation were done because most patients tolerate
LV-2LV well, although some cases of re-expansion pulmonary edema were
eported.1 Re-expansion pulmonary edema was reported more after treatment of
neumothorax,2,3 but the mechanisms and preventive methods need to be substan-
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TSiated by stronger scientific evidence.4 A previous study on
obectomy in patients with lung cancer showed that lung
e-expansion from OLV provoked more severe oxidative
njuries than surgical intervention by measuring malondial-
ehyde (MDA), a product of lipid peroxidation, but resec-
ion of lung cancer can also decrease MDA levels.5 How-
ver, higher serial MDA levels were shown in patients with
ung cancer, and the injuries on lung parenchyma cannot be
xcluded in lobectomy.
The oxidative injuries are started from an excessive free
adical production that cannot be counteracted by the action
f endogenous antioxidant defense. Our preliminary data
howed an abrupt increase of reactive oxygen species
ROS) production after resuming 2LV from OLV. On the
ther hand, antioxidants were reported to be decreased in
ulmonary edema fluids in acute lung injury.6 To investi-
ate the effects on oxidant-antioxidant balance of OLV-
LV, total antioxidant status (TAS) assay levels were mea-
ured, as was ROS production. Free radicals have been
eported involved in pulmonary reperfusion injuries, includ-
ng superoxide7 and H2O2,8 and thus lucigenin9 and lumi-
ol10 chemiluminescence (CL) were used in this study to
btain a more specific detection of superoxide, HOCl, and
2O2.
The hallmark of oxidative lung injury is endothelial cell
amage, which is reflected in increased pulmonary vascular
ermeability. In an animal study re-expansion of the atelec-
atic lung causes a significant increase in permeability and
ulmonary hypertension,11 with subsequent edema forma-
ion and hypoxemia.12 Reperfusion-induced vascular leak-
ge was reported to peak at 30 minutes in rat blood-perfused
ungs,13 and superoxide dismutase was shown to prevent it
ompletely.14 Concerning a previous clinical study, albumin
ermeability was frequently applied through lavage, but it is
ifficult to evaluate the extent of pulmonary vascular leak-
ge, especially in patchy edema. In this study the PiCCO
Abbreviations and Acronyms
CL  chemiluminescence
CO  cardiac output
CVP  central venous pressure
EVLW extravascular lung water
FIO2  fraction of inspired oxygen
GEDV  global end-diastolic volume
ITBV  intrathoracic blood volume
MDA malondialdehyde
OLV  1-lung ventilation
ROS  reactive oxygen species
TAS  total antioxidant status
2LV  2-lung ventilation
VATS  video-assisted thoracoscopic surgeryystem (Pulsion Medical Systems, Munich, Germany) was s
14 The Journal of Thoracic and Cardiovascular Surgery ● Septepplied to measure extravascular lung water (EVLW), car-
iac output (CO), and intrathoracic blood volume (ITBV)
evels by means of the transpulmonary indicator dilution
echnique because it has been proved effective in preload,
VLW measurement,15 and pulmonary permeability index
eterination,16 including in patients undergoing lung
ransplantation.17
The goals of this study were (1) to measure ROS pro-
uction, as well as TAS levels, during OLV-2LV with
inimal pulmonary injury in video-assisted thoracoscopic
urgery (VATS) and (2) to explore the effects of OLV-2LV
n EVLW, CO, and ITBV by using the Pulsion PiCCO
ystem.
atients and Methods
ith ethics committee approval and written informed consent, 20
dult patients (American Society of Anesthesiologists [ASA]
hysical status class I-II, 25-60 years old) scheduled for VATS that
nvolved a long period of intraoperative OLV (60 minutes) with
inimal lung trauma were studied. Patients with recent vitamin
ngestion were excluded. Anesthesia was induced with thiopental
3-5 mg/kg), fentanyl (3 ug/kg), and pancuronium (0.1 mg/kg).
fter induction of anesthesia, an appropriate size of left bronchial
atheter (Broncho-Cath, Mallinckrodt) was intubated and adjusted
y using a fiberoptic bronchoscope before and after turning to the
ateral decubitus position. Incremental doses of pancuronium were
dded for muscle relaxation. Isoflurane (1%-2%) was used to
aintain the anesthesia. Intermittent positive ventilation was per-
ormed with a volumetric ventilator (Fabius GS, Dräger). A 4F
beroptic thermistor (Pulsiocath, Pulsion Medical Systems) was
dvanced into the descending aorta through a femoral artery and
onnected to the integrated fiberoptic monitoring system. A central
enous line was inserted through the right internal jugular vein,
nd another arterial line was inserted through the right radial artery
or monitoring and blood gas analysis. Systolic arterial blood
ressure, diastolic arterial blood pressure through the arterial line,
eart rate, central venous pressure (CVP), electrocardiography,
ulse oximetry, body temperature, urine output, and peak airway
ressure were monitored continuously. Intravenous crystalloid and
entanyl were titrated to maintain the systolic blood pressure
ithin 15% of preinduction values. Ventilation was delivered
echanically. When OLV was started, the nondependent lung was
ollapsed and opened to air with suction if necessary, and the
ependent lung was ventilated at a fraction of inspired oxygen
FIO2) of 1, a tidal volume of 8 to 10 mL/kg, a respiratory rate of
2 to 16 breaths/min adjusted to maintain the arterial carbon
ioxide between 35 and 45 mm Hg, and an inspiration:expiration
atio of 1:2. The concentrations of inspiratory and expiratory gas
ixture (FIO2, end-tidal CO2, fraction of inspired isoflurane, and
nd-tidal isoflurane) were continuously monitored (Capnomac Da-
ex). Direct observation of the collapsed lung was monitored in the
perative hemithorax.
iCCO Monitoring
he CO and volumetric variables were obtained through the
ranspulmonary indicator dilution technique. The mean of 3 sub-
equent CO measurements were obtained. Fifteen milliliters of
mber 2006
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G
TSold saline (8°C) was injected through the distal port of the CVP.
O was calculated by using the thermodilution curve through the
mbedded thermistor in a femoral arterial catheter. ITBV and
VLW were calculated by using the mean transit time methods, as
escribed previously.18
xperimental Protocol
rterial blood gases were monitored 10 and 30 minutes after OLV
o avoid hypoxemia during the operation. Six-milliliter blood
amples were drawn from the arterial line after stabilization in the
ecubitus position after induction and before starting OLV as a
aseline (T1), after surgical incision and at the end of OLV
mmediately before resuming 2LV (T2), and 5 minutes (T3) and
0 minutes (T4) after resuming 2LV for measurement of ROS
roduction and TAS assay. One-milliliter blood samples were
mmediately wrapped in aluminum foil and kept on ice until CL
easurement for ROS production determination within 2
ours.19 Five-milliliter blood samples were placed into tubes
ontaining ethylenediamine tetraacetic acid. Sera were sepa-
ated (at 2000 rpm for 10 minutes) immediately after sampling
nd were stored at 80°C until determination of TAS was done
ithin 4 weeks.
CL measurement for ROS production. Immediately before
L measurement, 0.1 mL of phosphate-buffered saline buffer (pH
.4) was added to a 0.2-mL blood sample. The CL was measured
n a completely dark chamber of the CL analyzing system. After
00-second background level determination, 1.0 mL of 0.1
mol/L lucigenin or 1.0 mL of 0.1 mmol/L luminol in phosphate-
uffered saline (pH 7.4) was injected into the sample. The CL was
ontinuously monitored for an additional 600 seconds; integrating
he area under the curve and subtracting it from the background
evel was used to calculate the total amount of CL. The assay was
erformed in duplicate for each sample and was expressed as CL
ounts per 10 seconds for whole-blood CL.
TAS assay. The total antioxidant status in 20 L of plasma
ABLE 1. Changes of hemodynamic data, extravascular
olume, and cardiac output during 1-lung ventilation/2-lun
Baseline
T1
ABP (mm Hg) 127.3 18.9 126
ABP (mm Hg) 66.7 13.1 73
R (beats/min) 78.4 9.2 83
VP (mm Hg) 8.7 1.2 9
O2/FIO2 442.2 116.7 155
CO2 (mm Hg) 38.5 3.0 40
O (L/min) 4.5 0.4 5
VLW (mL) 480 211 53
TBV (mL) 1361 309 115
EDV (mL) 1091 317 92
ata are presented as means  standard deviation. OLV, One-lung ven
iastolic arterial blood pressure; HR, heart rate; CVP, central venous press
ung water; ITBV, intrathoracic blood volume; GEDV, global end-diastolic v
efore resuming 2-lung ventilation; T3, 5 minutes after resuming 2-lung ven
ompared with baseline data (T1), P  .05.r distilled water (as a blank) was measured with a TAS kit P
The Journal of Thoraciccatalog no. NX2332, Randox), according to the manufacturer’s
nstructions.20
Measurement of CO, EVLW, ITBV, and global end-diastolic
olume. At T1, T2, T3, and T4, a thermodilution curve was
ecorded in the aorta with the thermistor-tipped fiberoptic catheter.
O was continuously shown after calibration. EVLW and ITBV
ere determined by using the thermal dilution curve from 3
uccessive measurements.21 The permeability index was calcu-
ated as follows: EVLW/(ITBV  GEDV), where GEDV is the
lobal end-diastolic volume.
tatistical Analysis
alues are expressed as means  standard deviation. Means 
tandard error are shown in figures. Significant differences be-
ween groups were analyzed with the 1-way analysis of variance
est. Pearson product moment correlation was used to clarify the
elation between lucigenin CL and EVLW, GEDV and ITBV, and
O and EVLW.
esults
hanges in Hemodynamics, Oxygenation, CO, EVLW,
TBV, and GEDV
he characteristics of the patients undergoing VATS were
s follows: 12 patients for a thymus tumor (5 with myas-
henia gravis) and the other 8 patients for esophagectomy (5
ith esophageal reconstruction), age of 40  15 years, 13
ale and 7 female patients, and OLV time of 118  33
inutes. As shown in Table 1, hemodynamic data during
LV and 2LV, including systolic arterial blood pressure,
iastolic arterial blood pressure, heart rate, and CVP, did
ot change significantly during the study. The PO2 values
ecreased significantly after OLV and were comparable
nonsignificantly lower) to baseline values after 2LV.
water, intrathoracic blood volume, global end-diastolic
ntilation
2LV
T3 T4
13.8 125.7 12.5
12.2 65.7 9.5
8.6 83.6 8.1
1.1 9.7  1.1
108.9* 403.1 134.2
3.2 39.8  2.8
1.3 5.4  1.4 5.5 1.3*
277 545 219 552 197
245 1366 650 1233 318
196 1094 440 1004 248
n; 2LV, 2-lung ventilation; SABP, systolic arterial blood pressure; DABP,
FIO2, fraction of inspired oxygen; CO, cardiac output; EVLW, extravascular
. Sampling time: T1, baseline before one-lung ventilation; T2, immediately
n; T4, 30 minutes after resuming 2-lung ventilation. *Significantly differentlung
g ve
OLV
T2
.2
.3
.4
.3
.6
.5
.0
6
4
3
tilatio
ure;
olume
tilatioositive end-expiratory pressure was not added in our
and Cardiovascular Surgery ● Volume 132, Number 3 515
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G
TSatients because of satisfactory oxygenation during OLV.
EDV and ITBV changed nonsignificantly, and EVLW
ncreased nonsignificantly. CO increased nonsignifi-
antly at 5 minutes after 2LV but increased significantly
t 30 minutes after 2LV. The permeability index was
tatistically nonsignificant.
OS Production by Means of Luminol and Lucigenin
L and TAS Assay During OLV and 2LV
he baseline of ROS production was as follows: lucigenin
L, 11,678  5897 (counts/per 600 seconds); luminol CL,
3,905  28,149 (counts/per 600 seconds). As shown in
igure 1, lucigenin CL increased significantly at 5 and 30
inutes after resuming 2LV (P  .001). Lucigenin CL
ncreased to 5 times at T3 and 11 times at T4 compared with
he data from T1. Luminol CL increased nonsignificantly
bout 2 times at T3 and 1.5 times at T4 compared with the
ata from T1. TAS increased at T2 and decreased at T3 and
4 nonsignificantly.16 The Journal of Thoracic and Cardiovascular Surgery ● Septeelationships Between Lucigenin CL and EVLW,
EDV and ITBV, and CO and EVLW
here is no significant relationship between ROS produc-
ion by lucigenin CL and EVLW. As shown in Figure 2,
here is a positive correlation between GEDV and ITBV
r  0.997, P  .05). There is a negative correlation
etween CO and EVLW (r  0.431, r2  0.168, P 
005, power of performed test:   .05: 0.93). EVLW tends
o decrease while CO increases.
iscussion
ur results revealed that OLV-2LV manipulation induces a
assive ROS production, even with minimal pulmonary
njury. This is the first report about ROS production but not
xidative metabolites during OLV-2LV. Detection of ROS
n vivo is technically more difficult because of their rapid
eactivity and short lifespan. However, it might be more
mportant to measure ROS production than lipid hydroper-
xides because some critically ill patients were reported to
Figure 1. ROS production and TAS levels during
OLV and 2LV. ROS, reactive oxygen species; TAS,
total antioxidant status; OLV, 1-lung ventilation;
2LV, 2-lung ventilation.
Figure 2. Relationships between EVLW and CO,
GEDV and ITBV. EVLW, extravascular lung water;
CO, cardiac output; GEDV, global end-diastolic
volume; ITBV, intrathoracic blood volume.mber 2006
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TSave decreased total antioxidant capacity with normal lipid
eroxidation. It was shown in our study that superoxide
roduction was more pronounced than HOCl and H2O2
roduction. It is also reported that superoxide induces reper-
usion oxidative injuries in a previous animal study.14
TAS levels were slightly decreased but still well main-
ained after resuming 2LV, with a nonsignificant decrease of
O2/FIO2. The baseline TAS level in this study was also
omparable with that of healthy patients.22 Our data con-
rmed that OLV-2LV manipulation in VATS, as well as in
obectomy, can induce a massive superoxide production, but
he well-maintained TAS data also elucidate why most
atients tolerate OLV-2LV without complications. How-
ver, the magnitude of ROS production should not be ig-
ored because when antioxidant capacity is compromised, a
assive ROS production leads to severe oxidative injuries
n DNAs, proteins, and lipids. Most previous case reports
f severe re-expansion pulmonary edema were cases of
neumothorax. Re-expansion of collapsed lung for pneu-
othorax might induce more oxidative injuries because
f a longer collapse time, a lower TAS level in emer-
ency operations, and a stronger hypoxic vasoconstric-
ion in collapsed lung than that during anesthesia. The
ffects on EVLW during OLV-2LV in this study were
lso milder than those in lung transplantation23 because
he transplanted lung is nonventilated and nonperfused,
ut in patients undergoing VATS, atelectatic lungs were
till hypoperfused.
Lucigenin CL, luminol CL, and TAS data were compa-
able between T1 and T2. They reveal that with adequate
nesthesia, surgical stimulation and mechanical ventilation
ould not induce a significant ROS production or decrease
he antioxidant capacity.
The mechanisms of re-expansion pulmonary edema in-
lude the hydrostatic mechanisms and permeability mecha-
isms. A significant increase of CO on T4 was shown in our
tudy and might have resulted from reactive vasodilatation
f resuming 2LV. Although EVLW in a lung undergoing
e-expansion could be underestimated in this experiment
ecause PiCCO cannot measure the water content in each
ung, the negative correlation of EVLW and CO shown in
ur results did not agree with the hydrostatic mechanisms.
O was also increased in our study, but the data of EVLW
tands in contrast to that in Tan’s report in pneumothorax.24
owever, there were very few patients studied concerning
he pathogenesis of re-expansion pulmonary edema.25,26
espite previous research of alveolar barrier properties, the
echanisms that promote the alveolar entry of large quan-
ities of liquid remain inadequately understood, especially
n the alveolo-capillary barrier.27
As in a previous report, GEDV and ITBV correlated well
ith each other in this study. ITBV was shown to be moreensitive and responsive to fluid loading than pulmonary cap-
The Journal of Thoracicllary wedge pressure.28 In the pre-edematous condition fluid
anagement remains an important but difficult issue. In clin-
cal practice concerning impending pulmonary edema, the
iCCO Pulsion system provides a closer and beneficial mon-
tor on balancing the preload and EVLW compared with the
onventional chest radiographic examination.
We concluded that adequate antioxidant capacity to cap-
ure the significant ROS production might explain why
e-expansion pulmonary edema remains rare in OLV-2LV.
owever, a massive superoxide production after resuming
LV might result in a catastrophic pulmonary reperfusion in
he cases of inadequate antioxidant capacity, such as severe
rauma, sepsis, and emergency operations.
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